Arthritis Cure
by michaelhwoods | July 7, 2022 9:29 pm
Does anybody have any information on Ray Blanco[1]’s latest pitch for a small biotech firm’s imminent announcement of an Arthritis Cure as early as 7/11/22? Travis, how bout you? Thanks
Endnotes:
- Ray Blanco: https://www.stockgumshoe.com/tag/ray-blanco/
Source URL: https://www.stockgumshoe.com/2022/07/microblog-arthritis-cure/
I would also like to know.
I am trying to find out too.
MYMD Pharmaceuticals , I believe, based on “Dr. Chris” [Chapman] clue who Ray Blanco mentioned was named the “Honoree of the Year” by the American Arthritis Foundation.
when you google the patent number it comes up MYMD. Price is at $4.25.
Good idea to buy a stock when it rips to the upside. Its going to go up forever.
Articles on Yahoo Finance confirm the clues mentioned in Ray Blanco’s pitch.
The second box shows a patent application. Blurred. But I think it says Pharmaceutical Florida, which is a generic manufacturer. Nothing on their website.
You guys are good! It is indeed MYMD as per Ray himself.
Just got the email today from paradigm today – checked MYMD website for press releases today at 2:58 pm Pacific time – no press releases yet
If anyone is curious about MYMD, it might be a good time to take a look. It opened today at $4.99, now at 3 pm it’s $4.33 a share, the lowest since Ray’s big pitch.
Thanks, I believe he recommended to pay no more than $5.
All the way up to $3.58, 8/18/22 …..
Down from $5.80, 8/9/22
mymd still trading in the 3.50 range
Mymd is still trading in the 3.50 range – not much action yet
Mymd is still trading in the 3.50 range – not much action yet.
Like all of these endless pitches that don’t say you’ll have to fork up significant sums, I watched this interview today 8/4. Did any company actually announce anything confirming Blanco’s greatest thing that will change the world?
Missed this story while i was on vacation, but I did look into it today if anyone’s curious:
https://www.stockgumshoe.com/reviews/ray-blancos-catalyst-trader/de-tease-ray-blanco-and-james-altuchers-sub-5-arthritis-stock/